ULTA
Ulta Beauty, Inc. NASDAQ Listed Oct 25, 2007$456.13
+1.19%
vs $450.75
Mkt Cap $20.5B
52w Low $450.75
2.1% of range
52w High $706.82
50d MA $510.15
200d MA $563.69
P/E (TTM)
17.8x
EV/EBITDA
10.8x
P/B
7.3x
Debt/Equity
0.8x
ROE
41.1%
P/FCF
19.2x
RSI (14)
28.40
ATR (14)
$14.27
Beta
0.95
50d MA
$510.15
200d MA
$563.69
Avg Volume
868.1K
Ulta Beauty, Inc. operates as a retailer of beauty products in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; professional hair products; salon services, including hair, skin, makeup, and brow services; and nail services. It also provides its private label products, such as the Ulta Beauty Collection branded cosmetics, skincare, and bath products, as well as Ulta Beauty branded products; and the Ulta Beauty branded gifts. As of March 10, 2022, the company operated 1,308 retail stores across 50 states. It also distributes its products through its website ulta.com; and mobile applications. The company was formerly known as Ulta Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.
1000 Remington Boulevard · Bolingbrook, IL 60440 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | AMC | 6.89 | 7.74 | +12.3% | 494.87 | -3.3% | -4.8% | -1.8% | +1.0% | -0.9% | +3.3% | — |
| Mar 12, 2026 | AMC | 8.10 | 8.01 | -1.1% | 624.70 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% | — |
| Dec 4, 2025 | AMC | 4.61 | 5.14 | +11.5% | 533.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% | — |
| Aug 28, 2025 | AMC | 5.10 | 5.78 | +13.3% | 530.63 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% | — |
| May 29, 2025 | AMC | 5.81 | 6.70 | +15.3% | 421.79 | +11.0% | +11.8% | +0.9% | -0.5% | -1.6% | +0.3% | — |
| Mar 13, 2025 | AMC | 7.13 | 8.46 | +18.7% | 314.47 | +8.8% | +13.7% | -0.1% | -3.7% | -0.0% | -0.8% | — |
| Dec 5, 2024 | AMC | 4.53 | 5.14 | +13.5% | 392.87 | +9.0% | +9.0% | -2.4% | -1.5% | +4.4% | -1.4% | — |
| Aug 29, 2024 | AMC | 5.46 | 5.30 | -2.9% | 367.58 | -6.4% | -4.0% | +1.7% | +0.3% | +1.1% | +1.0% | — |
| May 30, 2024 | AMC | 6.24 | 6.47 | +3.7% | 385.58 | +9.2% | +2.5% | -1.3% | -0.1% | -0.6% | -0.6% | — |
| Mar 14, 2024 | AMC | 7.53 | 8.08 | +7.3% | 565.44 | -10.9% | -5.2% | -0.7% | -0.6% | -1.0% | -0.1% | — |
| Nov 30, 2023 | AMC | 4.95 | 5.07 | +2.4% | 425.99 | +11.6% | +10.8% | +3.1% | -1.1% | +2.7% | -0.9% | — |
| Aug 24, 2023 | AMC | 5.85 | 6.02 | +2.9% | 422.74 | +0.6% | -3.7% | +0.9% | +1.0% | +1.9% | -1.9% | — |
| May 25, 2023 | AMC | 6.87 | 6.88 | +0.1% | 485.12 | -10.1% | -13.4% | -3.2% | +0.8% | -1.5% | +4.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5 | BofA Securities | Upgrade | Neutral → Buy | $685 | $518.00 | $532.28 | +2.8% | +2.8% | +0.5% | -1.6% | -0.9% | -1.8% |
| Apr 20 | Jefferies | Upgrade | Hold → Buy | — | $553.36 | $559.00 | +1.0% | +3.4% | -0.4% | -1.1% | +0.1% | -1.0% |
| Apr 14 | DA Davidson | Maintains | Buy → Buy | — | $526.76 | $530.63 | +0.7% | +1.2% | +1.1% | +0.1% | +2.6% | +3.4% |
| Mar 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | TD Cowen | Maintains | Buy → Buy | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | Wells Fargo | Maintains | Underweight → Underweight | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | JP Morgan | Maintains | Overweight → Overweight | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $624.70 | $566.28 | -9.4% | -14.2% | -3.5% | +1.2% | -0.5% | +2.6% |
| Mar 11 | Evercore ISI | Maintains | Outperform → Outperform | — | $647.23 | $646.29 | -0.1% | +0.8% | -4.3% | -14.2% | -3.5% | +1.2% |
| Mar 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $642.22 | $635.57 | -1.0% | +0.8% | +0.8% | -4.3% | -14.2% | -3.5% |
| Mar 9 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $646.34 | $633.28 | -2.0% | -0.6% | +0.8% | +0.8% | -4.3% | -14.2% |
| Mar 9 | Barclays | Maintains | Overweight → Overweight | — | $646.34 | $633.28 | -2.0% | -0.6% | +0.8% | +0.8% | -4.3% | -14.2% |
| Mar 9 | Wells Fargo | Maintains | Underweight → Underweight | — | $646.34 | $633.28 | -2.0% | -0.6% | +0.8% | +0.8% | -4.3% | -14.2% |
| Jan 21 | Raymond James | Upgrade | Outperform → Strong Buy | — | $675.62 | $684.39 | +1.3% | +1.2% | -0.3% | +0.7% | -3.6% | -1.5% |
| Jan 21 | TD Cowen | Maintains | Buy → Buy | — | $675.62 | $684.39 | +1.3% | +1.2% | -0.3% | +0.7% | -3.6% | -1.5% |
| Jan 20 | Oppenheimer | Maintains | Outperform → Outperform | — | $663.48 | $662.79 | -0.1% | +1.8% | +1.2% | -0.3% | +0.7% | -3.6% |
| Jan 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $663.85 | $665.16 | +0.2% | +0.2% | -0.2% | +1.8% | +1.2% | -0.3% |
| Jan 8 | BofA Securities | Maintains | Neutral → Neutral | — | $655.36 | $651.79 | -0.5% | +0.3% | +1.3% | -0.7% | +0.5% | -0.2% |
| Jan 7 | UBS | Maintains | Buy → Buy | — | $650.06 | $649.87 | -0.0% | +0.8% | +0.3% | +1.3% | -0.7% | +0.5% |
| Jan 2 | Argus | Maintains | Buy → Buy | — | $605.01 | $606.12 | +0.2% | +2.5% | +1.8% | +3.0% | +0.8% | +0.3% |
| Dec 10 | Oppenheimer | Maintains | Outperform → Outperform | — | $602.97 | $603.05 | +0.0% | -0.4% | -1.2% | +1.4% | -1.7% | -0.3% |
| Dec 8 | TD Cowen | Upgrade | Hold → Buy | — | $601.50 | $611.84 | +1.7% | -2.0% | +2.3% | -0.4% | -1.2% | +1.4% |
| Dec 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $601.50 | $611.84 | +1.7% | -2.0% | +2.3% | -0.4% | -1.2% | +1.4% |
| Dec 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | DA Davidson | Maintains | Buy → Buy | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Guggenheim | Maintains | Neutral → Neutral | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Baird | Maintains | Outperform → Outperform | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | JP Morgan | Maintains | Overweight → Overweight | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 5 | UBS | Maintains | Buy → Buy | — | $533.95 | $578.95 | +8.4% | +12.7% | -2.0% | +2.3% | -0.4% | -1.2% |
| Dec 1 | JP Morgan | Maintains | Overweight → Overweight | — | $538.83 | $538.39 | -0.1% | +1.6% | +0.1% | -0.6% | -1.9% | +12.7% |
| Dec 1 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $538.83 | $538.39 | -0.1% | +1.6% | +0.1% | -0.6% | -1.9% | +12.7% |
| Oct 17 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $537.29 | $536.12 | -0.2% | -0.7% | -1.8% | +0.4% | -1.3% | +1.0% |
| Oct 16 | Wells Fargo | Maintains | Underweight → Underweight | — | $538.49 | $538.89 | +0.1% | -0.2% | -0.7% | -1.8% | +0.4% | -1.3% |
| Oct 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $561.15 | $564.72 | +0.6% | -2.1% | -1.2% | -0.4% | -0.5% | -0.2% |
| Sep 25 | Argus | Upgrade | Hold → Buy | — | $535.61 | $539.37 | +0.7% | +0.7% | +2.3% | +0.3% | -1.3% | +1.7% |
| Sep 8 | Telsey Advisory Group | Maintains | Outperform → Outperform | — | $514.86 | $518.95 | +0.8% | +1.0% | -1.1% | +0.3% | +1.2% | -1.4% |
| Sep 2 | Barclays | Maintains | Overweight → Overweight | — | $492.73 | $491.26 | -0.3% | +8.1% | -0.3% | -0.3% | -2.8% | +1.0% |
| Aug 29 | BofA Securities | Maintains | Neutral → Neutral | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Aug 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Aug 29 | Raymond James | Maintains | Outperform → Outperform | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Aug 29 | Goldman Sachs | Maintains | Buy → Buy | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Aug 29 | Evercore ISI | Maintains | Outperform → Outperform | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Aug 29 | Morgan Stanley | Maintains | Overweight → Overweight | — | $530.63 | $526.85 | -0.7% | -7.1% | +8.1% | -0.3% | -0.3% | -2.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | MRKONIC GEORGE R JR | — | Sell | 383 | $475.84 | $182K | 2,404 | -2.79% | — |
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Unable to provide meaningful analysis without specific disclosure content; the filing summary only shows boilerplate language and references a press release dated March 24, 2026—review the actual press release for material information.
Mar 24
8-K
Unknown — 8-K Filing
Ulta Beauty's fiscal 2026 guidance of 6-7% sales growth with 9.4-11.4% EPS growth, backed by share repurchases, signals margin expansion and shareholder returns despite modest top-line growth.
Mar 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 2,884,415 | $1.5B | New | Mar 2026 |
| 2 | Morgan Stanley | 2,181,250 | $1.3B | Reduced | Dec 2025 |
| 3 | Vanguard Portfolio Management Llc | 1,960,042 | $1.0B | New | Mar 2026 |
| 4 | Sanders Capital, Llc | 1,908,139 | $997M | Added | Mar 2026 |
| 5 | Jpmorgan Chase & Co | 1,104,673 | $563M | Added | Mar 2026 |
| 6 | Invesco Ltd. | 738,157 | $386M | Reduced | Mar 2026 |
| 7 | Franklin Resources Inc | 628,540 | $329M | Reduced | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 598,104 | $313M | Reduced | Mar 2026 |
| 9 | Northern Trust Corp | 558,895 | $292M | Reduced | Mar 2026 |
| 10 | Swedbank Ab | 533,655 | $279M | Reduced | Mar 2026 |
| 11 | Aqr Capital Management Llc | 504,757 | $261M | Added | Mar 2026 |
| 12 | Amundi | 476,481 | $249M | New | Mar 2026 |
| 13 | Alyeska Investment Group, L.p. | 472,672 | $247M | Added | Mar 2026 |
| 14 | Agf Management Ltd | 356,318 | $216M | Added | Dec 2025 |
| 15 | Robeco Institutional Asset Management B.v. | 362,576 | $190M | Added | Mar 2026 |
| 16 | Ubs Group Ag | 282,691 | $148M | Reduced | Mar 2026 |
| 17 | Pictet Asset Management Holding Sa | 236,983 | $143M | Added | Dec 2025 |
| 18 | Bank Of New York Mellon Corp | 251,119 | $131M | Reduced | Mar 2026 |
| 19 | Qube Research & Technologies Ltd | 250,748 | $131M | Added | Mar 2026 |
| 20 | Alecta Tjanstepension Omsesidigt | 222,505 | $116M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$20.52B
Enterprise Value
$20.03B
P/E (TTM)
17.79x
Forward P/E
15.94x
PEG Ratio
22.87x
P/B
7.30x
P/S
1.66x
P/FCF
19.22x
EV/EBITDA
10.83x
Shares Out
45.0M
Financials (TTM)
Revenue
$12.39B
Net Income
$1.15B
EBITDA
$1.85B
Free Cash Flow
$1.07B
Op Cash Flow
$1.50B
EPS Basic
$25.72
EPS Diluted
$25.64
EPS Forward
$28.61
Gross Margin
39.1%
Op Margin
12.5%
Net Margin
9.3%
Balance Sheet
Total Assets
$7.00B
Total Liab.
$4.20B
Total Equity
$2.80B
Cash
$494.2M
LT Debt
$0
Book Value/Sh
$62.52
Debt/Equity
0.78x
Current Ratio
1.41
Quick Ratio
0.43
Returns & Growth
ROE
41.1%
ROA
16.5%
ROIC
22.8%
Rev Growth YoY
+9.7%
EPS Growth YoY
+1.1%
Price Returns
2W
+2.1%
1M
-5.3%
3M
-25.7%
6M
-5.6%
12M
+7.9%
Technicals
52W High
$706.82
52W Low
$450.75
50d MA
$510.15
200d MA
$563.69
RSI (14)
28.40
ATR (14)
$14.27
Beta
0.95
Avg Volume
868K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$727.36
High
$810.00
Low
$650.00
Median
$720.00
Data updated apr 27, 2026 6:44am
· Source: financialmodelingprep.com